Order Article Reprints

Antonioli L, Pellegrini C, Fornai M, Benvenuti L, D’Antongiovanni V, Colucci R, Bertani L, Di Salvo C, Semeghini G, La Motta C, et al. Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. International Journal of Molecular Sciences. 2021; 22(12):6325. https://doi.org/10.3390/ijms22126325

Antonioli, Luca, Carolina Pellegrini, Matteo Fornai, Laura Benvenuti, Vanessa D’Antongiovanni, Rocchina Colucci, Lorenzo Bertani, Clelia Di Salvo, Giorgia Semeghini, Concettina La Motta, and et al. 2021. "Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation" International Journal of Molecular Sciences 22, no. 12: 6325. https://doi.org/10.3390/ijms22126325

Antonioli, L., Pellegrini, C., Fornai, M., Benvenuti, L., D’Antongiovanni, V., Colucci, R., Bertani, L., Di Salvo, C., Semeghini, G., La Motta, C., Giusti, L., Zallocco, L., Ronci, M., Quattrini, L., Angelucci, F., Coviello, V., Oh, W.-K., Ha, Q. T. K., Németh, Z. H., ... Blandizzi, C. (2021). Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. International Journal of Molecular Sciences, 22(12), 6325. https://doi.org/10.3390/ijms22126325